Novavax (NVAX) closed at $9.34 in the latest trading session, marking a +1.3% move from the prior day. The average of price targets set by Wall Street analysts indicates a potential upside of 81.6 ...

Novavax (NVAX) closed at $9.34 in the latest trading session ... Novavax is working with the FDA to explore a pathway for accelerated approval of the COVID-19-flu combination and standalone flu ...

These awards were approved ... to use the latest selected strain and the guidance from the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and World Heal Novavax, Inc ...

Novavax’s COVID-19 vaccine produced higher levels of neutralising antibodies than produced by recovered patients in an early trial, paving the way for a phase 3 trial and potential approval by ...

International: Kennedy also gave Cassidy assurances over vaccines, as the 70-year-old environmental lawyer has long sown ...

The phase 3 trial – which takes Novavax’ NVX‑CoV2373 shot a step closer to approval – also found that it was 100% effective in preventing severe COVID-19. Novavax has said it intends to ...

Provincial governments have opened up eligibility for booster doses in an effort to blunt the latest wave ... GlaxoSmithKline, Novavax and J&J. So far, Health Canada has approved the Moderna ...

NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with a market capitalization of $150 billion and annual revenue exceeding $59 billion, announced today that its Phase 3 BREAKWATER study ...

Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

The latest figures include 39% who Strongly Approve of the job Trump is doing and 38% who Strongly Disapprove. This gives him a Presidential Approval ... on events in the news and other topics ...

The latest figures include 39% who Strongly Approve of the job Trump is doing and 37% who Strongly Disapprove. This gives him a Presidential Approval ... on events in the news and other topics ...